162 related articles for article (PubMed ID: 8265236)
1. Flucloxacillin induced liver disease: histopathological findings at biopsy and autopsy.
Eckstein RP; Dowsett JF; Lunzer MR
Pathology; 1993 Jul; 25(3):223-8. PubMed ID: 8265236
[TBL] [Abstract][Full Text] [Related]
2. Flucloxacillin induced delayed cholestatic hepatitis.
Miros M; Kerlin P; Walker N; Harris O
Aust N Z J Med; 1990 Jun; 20(3):251-3. PubMed ID: 2372276
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis.
Davies MH; Harrison RF; Elias E; Hübscher SG
J Hepatol; 1994 Jan; 20(1):112-6. PubMed ID: 8201211
[TBL] [Abstract][Full Text] [Related]
4. Prolonged hepatic cholestasis after flucloxacillin therapy.
Turner IB; Eckstein RP; Riley JW; Lunzer MR
Med J Aust; 1989 Dec 4-18; 151(11-12):701-5. PubMed ID: 2593915
[TBL] [Abstract][Full Text] [Related]
5. Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?
Devereaux BM; Crawford DH; Purcell P; Powell LW; Roeser HP
Eur J Clin Pharmacol; 1995; 49(1-2):81-5. PubMed ID: 8751026
[TBL] [Abstract][Full Text] [Related]
6. Successful liver transplantation for drug-induced vanishing bile duct syndrome.
Hashim A; Barnabas A; Miquel R; Agarwal K
BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31948982
[TBL] [Abstract][Full Text] [Related]
7. Flucloxacillin-associated hepatic injury.
Koek GH; Stricker BH; Blok AP; Schalm SW; Desmet VJ
Liver; 1994 Oct; 14(5):225-9. PubMed ID: 7997079
[TBL] [Abstract][Full Text] [Related]
8. A histopathological study of the liver in paraquat poisoning--an analysis of fourteen autopsy cases with emphasis on bile duct injury.
Matsumoto T; Matsumori H; Kuwabara N; Fukuda Y; Ariwa R
Acta Pathol Jpn; 1980 Nov; 30(6):859-70. PubMed ID: 7446116
[TBL] [Abstract][Full Text] [Related]
9. Flucloxacillin-induced liver injury.
Andrews E; Daly AK
Toxicology; 2008 Dec; 254(3):158-63. PubMed ID: 18793693
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for development of flucloxacillin associated jaundice.
Fairley CK; McNeil JJ; Desmond P; Smallwood R; Young H; Forbes A; Purcell P; Boyd I
BMJ; 1993 Jan; 306(6872):233-5. PubMed ID: 8443520
[TBL] [Abstract][Full Text] [Related]
11. Histologic changes mimicking biliary disease in liver biopsies with venous outflow impairment.
Kakar S; Batts KP; Poterucha JJ; Burgart LJ
Mod Pathol; 2004 Jul; 17(7):874-8. PubMed ID: 15098006
[TBL] [Abstract][Full Text] [Related]
12. Neonatal giant cell hepatitis: histological and etiological findings.
Torbenson M; Hart J; Westerhoff M; Azzam RK; Elgendi A; Mziray-Andrew HC; Kim GE; Scheimann A
Am J Surg Pathol; 2010 Oct; 34(10):1498-503. PubMed ID: 20871223
[TBL] [Abstract][Full Text] [Related]
13. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
Hubscher SG; Lumley MA; Elias E
Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
[TBL] [Abstract][Full Text] [Related]
14. Liver damage from flucloxacillin, cloxacillin and dicloxacillin.
Olsson R; Wiholm BE; Sand C; Zettergren L; Hultcrantz R; Myrhed M
J Hepatol; 1992 May; 15(1-2):154-61. PubMed ID: 1506634
[TBL] [Abstract][Full Text] [Related]
15. [Hepatic neoductules].
Fischer HP; Meybehm M; Zhou H; Schoch J
Verh Dtsch Ges Pathol; 1995; 79():36-46. PubMed ID: 8600693
[TBL] [Abstract][Full Text] [Related]
16. Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.
Fickert P; Fuchsbichler A; Marschall HU; Wagner M; Zollner G; Krause R; Zatloukal K; Jaeschke H; Denk H; Trauner M
Am J Pathol; 2006 Feb; 168(2):410-22. PubMed ID: 16436656
[TBL] [Abstract][Full Text] [Related]
17. Histopathology of cholestasis.
Desmet VJ
Verh Dtsch Ges Pathol; 1995; 79():233-40. PubMed ID: 8600686
[TBL] [Abstract][Full Text] [Related]
18. Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes.
Lakehal F; Dansette PM; Becquemont L; Lasnier E; Delelo R; Balladur P; Poupon R; Beaune PH; Housset C
Chem Res Toxicol; 2001 Jun; 14(6):694-701. PubMed ID: 11409940
[TBL] [Abstract][Full Text] [Related]
19. Meropenem-induced vanishing bile duct syndrome.
Schumaker AL; Okulicz JF
Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
[TBL] [Abstract][Full Text] [Related]
20. Flucloxacillin-Induced Hepatotoxicity - Association with HLA-B*5701.
Teixeira M; Macedo S; Batista T; Martins S; Correia A; Matos LC
Rev Assoc Med Bras (1992); 2020; 66(1):12-17. PubMed ID: 32130375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
